consider discontinuation | | Cyclosporine / tacrolimus | Gastric emptying delay
The FDA lifted a warning letter issued regarding the companys manufacturing facility in Ingelheim, Germany that cited cGMP violations for the manufacture of APIs and finished products
Gastrointestinal side effects were the most commonly reported adverse events, including nausea, constipation, and diarrhea, most of which were mild to moderate in severity
Food & Drug Administration, 2024 NIH: National Library of Medicine PubMed, 2024 Manufacturer Prescribing Information Novo Nordisk / Eli Lilly, 2024
Weight loss can happen without this symptom at all for everyone
Suppliers that stock Retatrutide typically position it within metabolic or obesity-focused research categories, emphasizing its multi-receptor profile as a rationale for broader study in energy balance and weight-related models